Cure My Disease

Don't miss your cure!

 Log in / Sign up

Steroids before birth may alter Baby's blood counts

NCT ID NCT07358845

Knowledge-focused Sponsor: Princess Anna Mazowiecka Hospital, Warsaw, Poland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether steroids given to pregnant women before a premature delivery change the baby's blood counts. Researchers observed over 1000 premature infants and compared their blood results based on when and how much steroid the mother received. The goal was to understand these effects, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,048 people

The number who actually took part.

Started

Jan 2011

Finished

Dec 2013

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

We planned to recruit all consecutive pairs: pregnant women and their preterm infants admitted \>24 and ≤ 36 weeks of gestation.

Ages

0 days to 1 day

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * gestational age 24 weeks - \<36 weeks Exclusion Criteria: * gestational age \<24 and⩾36 * major congenital or chromosomal abnormalities * intrauterine foetal demise * women with active or suspected cancer * women underwent surgery or chemotherapy during pregnancy * women whose pregnancy was prematurely terminated due to maternal indications * women who received ANS outside of our hospital * lack of parental consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Haematology are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematologic disorder Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Haematology

Contacts and locations

Locations

  • Department of Obstetrics and Gynecology, Department of Neonatology and Neonatal Intensive Care, Warsaw, Medical University of Warsaw, Poland

    Warsaw, Warsaw, 00-315, Poland

  • Department of Obstetrics and Gynecology, Warsaw, Medical University of Warsaw, Poland

    Warsaw, 00-315, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.